Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Narrowing Losses Amidst Pipeline Progress VABK Q1 2026 Earnings EPS of 097 Reported Amid Modest Stock Decline TD SYNNEX SNX Q1 2026 Earnings Massive EPS Beat Drives Optimism Revenue Not Disclosed CPNG Q1 2026 Earnings EPS Misses by Over 200 Amid Strategic Investments Shares Rise 277 ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status West Pharmaceutical Services WST Q1 2026 Earnings Strong EPS Surprise of 258 Outpaces Estimates